https://www.selleckchem.com/pr....oducts/sch-442416.ht
ensive study is encouraged to promote disease-specific ADs among Chinese patients with brain tumours. ADs and end-of-life care have been poorly acknowledged among patients with brain tumours in mainland China. Additional efforts should be encouraged amongst patients with primary brain tumours, those who are undergoing surgery and radiotherapy and those who have low socioeconomic status. A longitudinal and comprehensive study is encouraged to promote disease-specific ADs among Chinese patients with brain tumours. In people with albini
Like
Comment
Share
